BRNS: Barinthus Biotherapeutics PLC Sotuvga nisbatan narx

Barinthus Biotherapeutics PLC (BRNS) kompaniyasining korporativ logotipi

Xorijiy laboratoriyalarning diversifikatsiyalashgan jamlanmasi Barinthus Biotherapeutics uchun tadqiqotlarning uzluksizligini ta'minlaydi va yuqori marjali virusli patologiya terapiyalariga bo'lgan barqaror talabni qo'llab-quvvatlaydi. P/S vaqtlar ketma-ketligi bozor kutganlarini aks ettiradi, bunda 2.90 qiymati joriy multiplikatorni ko'rsatadi. T-hujayralar aktivatsiyasi orqali saraton va gepatitga qarshi kurashish uchun VTP ekotizimining rivojlanishi bemorlarni to'liq sog'aytirish imkoniyatini yaratadi.

Barinthus Biotherapeutics - BRNS P/S multiplikatori (davr: 21.02.2024 - 10.11.2025)

barinthusbio.com (BRNS) kompaniyasining tahliliy kesimlari

Kompaniyaning fundamental tahlili:Barinthus Bio (BRNS)
Barinthus Biotherapeutics tayyor mahsulotlari

Gepatit B ga qarshi kurashish uchun VTP platformasining ishlab chiqilishi global virologiya bozorida Barinthus Biotherapeutics (BRNS) texnologiyalari uchun tijoratlashtirish imkoniyatlarini yaratadi. Bozor kapitalizatsiyasining yillik daromadga nisbati ushbu operatsion kutuvlarni aniq investitsiya koeffitsientiga aylantiradi. Ushbu metrika sotuvlarning har bir dollari narxini belgilab, kelajakdagi o'sishning qanchalik darajada narxga kiritilganini aks ettiradi. Sotuvlar nisbatini (price-to-sales ratio) tahlil qilish orqali investor biotexnologiya kompaniyasining innovatsion maqomi uchun to'langan premiumni baholaydi.

Barinthus Biotherapeutics kimlar bilan raqobatlashadi

argenx - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (biontech.de)|Abivax Corp (ABVX) - Sotuvga nisbatan narx|ADMA Corp - P/S multiplikatori|Narxning sotuvga nisbati PTGX|Immunovant Inc (IMVT) - Narxning daromadga nisbati|KNSA - Narx/daromad koeffitsiyenti|GRFS (Grifols Biemat) - P/S multiplikatori|P/S multiplikatori Adaptive Biotechnologies Inc.|Narxning daromadga nisbati Celldex Therapeutics (CLDX)|Narx/daromad koeffitsiyenti auriniapharma.com|Narxning daromadga nisbati BioCryst Pharmaceuticals BCRX|Bozor kapitallashuvining daromadga nisbati VERA|Dianthus Pharma - P/S multiplikatori|PHVS - P/S multiplikatori|ABCL: P/S multiplikatori|TRML (Tourmaline Bio, Inc.) - Narxning daromadga nisbati|Narxning daromadga nisbati Intrexon|PHAR - Narx/daromad multiplikatori|P/S multiplikatori NKTR|Narxning daromadga nisbati UPB (Upstream Bio Corp)|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|Narx/daromad koeffitsiyenti immunome.com (IMNM)|Gossamer Bio Inc - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati KALV (KalVista Pharmaceuticals, Inc.)|SEPN: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Pieris Pharmaceuticals Inc|Kapitalizatsiyaning daromadga nisbati SVRA|Kapitalizatsiyaning daromadga nisbati Rigel Pharmaceuticals (RIGL)|P/S multiplikatori ANAB|ATXS - Sotuvga nisbatan narx|Narxning daromadga nisbati enGene Corp ENGN|Narx/daromad koeffitsiyenti RAPT Therapeutics, Inc. (RAPT)|Aerovate - P/S multiplikatori|ACRS - P/S multiplikatori|KYTX (Kyverna Therapeutics) - Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan narx Tiziana Life Sciences Ltd. (TLSA)|Kapitalizatsiyaning daromadga nisbati CABA|Ventyx Biosciences (VTYX) - Narx/daromad koeffitsiyenti|P/S multiplikatori THTX|AVTX (Avalo Therapeutics, Inc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ELDN (eledon.com)|AGEN - Kapitalizatsiyaning daromadga nisbati|CLYM - Narxning daromadga nisbati|Narxning sotuvga nisbati ZURA|ATYR: P/S multiplikatori|Adagene Corp (ADAG) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati IMA|Shattuck Labs, Inc. - Narxning sotuvga nisbati|Narxning daromadga nisbati Equillium Inc (EQ)|P/S multiplikatori Connect Biopharma Holdings (CNTB)|Narxning daromadga nisbati Immunic, Inc. IMUX|P/S multiplikatori Atara Biotherapeutics ATRA|IFRX - Narxning daromadga nisbati|XFOR: Narxning daromadga nisbati|ACET: P/S multiplikatori|CELU - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati inmunebio.com|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|AKTX (Akari Therapeutics Plc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Narxning daromadga nisbati|GOVX: Kapitalizatsiyaning daromadga nisbati|edesabiotech.com (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO: P/S multiplikatori|CARM - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati XTLB|Kapitalizatsiyaning daromadga nisbati boltbio.com (BOLT)|Narxning daromadga nisbati HCW Biologics Inc (HCWB)|P/S multiplikatori Aptevo Therapeutics, Inc. (APVO)|Narxning daromadga nisbati aimimmuno.com AIM|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio Corporation - P/S multiplikatori|XORTX Corp (XRTX) - Kapitalizatsiyaning daromadga nisbati|HIND (Vyome Holdings Inc.) - Kapitalizatsiyaning daromadga nisbati|revbiosciences.com (REVB) - P/S multiplikatori|INDP (Indaptus Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Scinai Immunotherapeutics Ltd (SCNI)|Narxning daromadga nisbati CalciMedica Inc (CALI)|AFMD (Affimed NV) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos Inc.)|P/S multiplikatori HOOKIPA HOOK|IGMS: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ITOS (iTeos)|OCEA: P/S multiplikatori|TCBP (TC BioPharm Ltd) - Narxning daromadga nisbati|THRD (Third Harmonic Bio Inc) - P/S multiplikatori